收藏切换
The regulatory role of E2F1 in prostate cancer
收藏切换
PDF
Ming-yi ZHANG, Ming JI, Xiao-guang CHEN*
Acta Pharmaceutica Sinica | 2021, 56(3) : 654 - 660
Less
收藏切换
Acta Pharmaceutica Sinica | 2021, 56(3): 654-660
Reviews
The regulatory role of E2F1 in prostate cancer
Full
Ming-yi ZHANG, Ming JI, Xiao-guang CHEN*
Affiliations
  • State Key Laboratory of Bioactive Substances and Functions of Natural Medicines/Beijing Key Laboratory of Non-clinical Drug Metabolism and PK/PD Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2021-03-12 doi: 10.16438/j.0513-4870.2020-1813
Outline
收藏切换

E2F transcription factor 1 (E2F1) is a major member of the E2F transcription factor family and participates in a wide range of physiological regulatory processes, such as cell cycle, survival, apoptosis, and metabolism. It is proved that the activity of E2F1 is related to the G1/S phase regulation of the cell cycle dependent on tumor suppressor retinoblastoma protein (RB). Recent studies have shown that E2F1 is highly expressed in prostate cancer cells, manifested as an oncogene, and its expression level is closely related to the occurrence, development, and poor clinical prognosis of prostate cancer. Androgen receptor (AR) is the main driving factor for the growth and progression of prostate cancer, and the changes of AR pathway play a key role in the pathological progression of prostate cancer. This article provide a systematic and comprehensive summary on recently published articles to review the role of the E2F1 pathway in prostate cancer.

prostate cancer  /  E2F1  /  retinoblastoma  /  androgen receptor
Ming-yi ZHANG, Ming JI, Xiao-guang CHEN. The regulatory role of E2F1 in prostate cancer[J]. Acta Pharmaceutica Sinica, 2021 , 56 (3) : 654 -660 . DOI: 10.16438/j.0513-4870.2020-1813
Year 2021 volume 56 Issue 3
PDF
149
57
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2020-1813
  • Receive Date:2020-11-25
  • Online Date:2025-12-18
  • Published:2021-03-12
Article Data
Affiliations
History
  • Received:2020-11-25
  • Revised:2021-01-11
Funding
Affiliations
    State Key Laboratory of Bioactive Substances and Functions of Natural Medicines/Beijing Key Laboratory of Non-clinical Drug Metabolism and PK/PD Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2020-1813
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT